Study guide

4.3 Personality Disorders, PTSD & Severe Mental Illness

IC&RC Advanced Alcohol & Drug Counselor AADC

Track your progress as you read

Finished sections get a check mark.

1 Chapter 1: Exam Overview & Master's-Level Credentialing

1.1 IC&RC AADC Exam Purpose, Structure & Scoring 1.2 Master's-Level Preparation Strategy & Exam Blueprint Navigation

2 Chapter 2: Diagnostic Systems & DSM-5-TR Substance Use Disorders

2.1 DSM-5-TR Diagnostic Criteria & Severity Continuum 2.2 Substance Classes, Intoxication & Withdrawal Syndromes 2.3 Neurobiology of Addiction & Tolerance Mechanics

3 Chapter 3: Standardized Screening, Comprehensive Assessment & Diagnostic Feedback

3.1 Clinical Distinctions Between Screening and Assessment 3.2 Evidence-Based Assessment Instruments 3.3 Selecting Culturally Appropriate Screening and Assessment Tools 3.4 Biopsychosocial Intake Interviewing & Stage-of-Change Assessment 3.5 Documenting Screening and Assessment Results 3.6 Discussing Diagnostic Results and Recommendations

4 Chapter 4: Complex Co-Occurring Psychiatric Disorders & Differential Diagnosis

4.1 Differential Diagnosis Principles: Primary vs Substance-Induced Disorders 4.2 Co-Occurring Depressive, Bipolar & Anxiety Disorders 4.3 Personality Disorders, PTSD & Severe Mental Illness

5 Chapter 5: Trauma, Suicide Risk & Crisis Engagement

5.1 Trauma Assessment & Complex Post-Traumatic Stress 5.2 Lethality & Suicide Risk Formulation 5.3 Crisis Intervention & Motivational Engagement

6 Chapter 6: ASAM Criteria & Multidimensional Level of Care Placement

6.1 ASAM Six Assessment Dimensions 6.2 ASAM Continuum of Care Levels 6.3 Level-of-Care Transitions, Continued Stay & Discharge

7 Chapter 7: Treatment Planning & SMART Goal Formulation

7.1 Problem Identification & Clinical Formulation 7.2 SMART Goals, Objectives & Interventions 7.3 Treatment Plan Evolution, Ongoing Review & Documentation 7.4 Educating the Person Served About the Counseling Process

8 Chapter 8: Pharmacotherapy & Medications for Substance Use Disorders

8.1 Medications for Opioid Use Disorder (MOUD) 8.2 Medications for Alcohol and Tobacco Use Disorders 8.3 Psychiatric Pharmacotherapy & The Counselor's Role

9 Chapter 9: Interprofessional Collaboration, Care Coordination & Referral

9.1 Multidisciplinary Teamwork & Integrated Healthcare 9.2 Referral Processes & Continuity of Care 9.3 Coordination with Specialized Systems

10 Chapter 10: Cognitive Behavioral Therapy & Relapse Prevention

10.1 Theoretical Foundations of CBT in Addiction 10.2 Cognitive Restructuring & Behavioral Coping Skills 10.3 Relapse Prevention Models & The Abstinence Violation Effect 10.4 Community Reinforcement & Third-Wave CBT Approaches

11 Chapter 11: Motivational Interviewing & Motivational Enhancement Therapy

11.1 Spirit & Foundational Principles of Motivational Interviewing 11.2 Four Processes & OARS Core Clinical Skills 11.3 Motivational Enhancement Therapy Protocol & Change Talk

12 Chapter 12: Contingency Management, Twelve-Step Facilitation & Third-Wave Behavioral Approaches

12.1 Operant Conditioning & Contingency Management Protocols 12.2 Twelve-Step Facilitation (TSF) Therapy 12.3 Mindfulness-Based Relapse Prevention (MBRP) & Acceptance Approaches 12.4 Multiple Pathways of Recovery & Adapting Intervention Strategies

13 Chapter 13: Family Systems, Adolescent Considerations & Group Psychotherapy

13.1 Family Systems Approaches in Addiction Treatment 13.2 Adolescent-Specific Assessment & Evidence-Based Interventions 13.3 Group Psychotherapy Dynamics & Facilitation

14 Chapter 14: Psychoeducation, Health Promotion & Infectious Disease

14.1 Medical & Health Consequences of Chronic Substance Use 14.2 Infectious Diseases: HIV/AIDS, Viral Hepatitis & STI Transmission 14.3 Wellness, Lifestyle Modification & Holistic Recovery Support

15 Chapter 15: Confidentiality, 42 CFR Part 2 & Legal Mandates

15.1 Federal Confidentiality Laws: 42 CFR Part 2 Foundations 15.2 Comparing 42 CFR Part 2 and HIPAA: Consent & Disclosures 15.3 Medical Emergencies, Child/Elder Abuse & Mandated Reporting 15.4 Duty to Warn (Tarasoff) & Responding to Subpoenas and Court Orders

16 Chapter 16: Clinical Supervision Models, Competency Evaluation & Gatekeeping

16.1 Theoretical Frameworks & Models of Clinical Supervision 16.2 The Supervisory Relationship, Roles & Modalities 16.3 Competency Evaluation, Formative Feedback & Gatekeeping 16.4 Vicarious Liability, Legal Risks & Managing Impaired Counselors

17 Chapter 17: Professional Ethics, Boundaries & Multicultural Competence

17.1 Professional Codes of Ethics & Ethical Decision-Making Frameworks 17.2 Dual Relationships, Professional Boundaries & Conflict of Interest 17.3 Multicultural Competence, Cultural Humility & Health Disparities 17.4 Technology, Telehealth & Digital Ethics in Addiction Counseling 17.5 Integrating Research Into Clinical Practice

4.3 Personality Disorders, PTSD & Severe Mental Illness

Key Takeaways Explain This Topic AI

Borderline Personality Disorder is characterized by severe affective instability, frantic abandonment fears, and splitting; Dialectical Behavior Therapy (DBT) is the evidence-based gold standard integrating mindfulness and distress tolerance.

Antisocial Personality Disorder strictly requires documented evidence of Conduct Disorder with onset before age 15; criminal behaviors occurring solely to sustain chemical dependency without adolescent conduct pathology do not constitute ASPD.

PTSD and substance use disorders operate via a mutual maintenance model and self-medication dynamics, requiring integrated trauma-informed care such as Seeking Safety to stabilize symptoms without premature exposure.

Primary psychotic disorders present with clear sensorium and auditory command hallucinations, whereas substance-induced toxic delirium is characterized by clouded consciousness, disorientation, and visual/tactile hallucinations.

The SAMHSA Four Quadrants model stratifies co-occurring severity to guide level-of-care placement, assigning high-psychiatric/high-addiction (Quadrant IV) clients to specialized integrated dual-disorder residential programs or ACT teams.

Last updated: September 2026

4.3 Personality Disorders, PTSD & Severe Mental Illness

In the advanced practice of addiction counseling, navigating severe co-occurring pathology—including Cluster B personality disorders, Post-Traumatic Stress Disorder (PTSD), and primary psychotic disorders—demands sophisticated clinical acumen. These complex presentations carry elevated risks of treatment attrition, relational conflict, medical complications, and behavioral crises.

To formulate effective treatment plans and establish safe clinical boundaries, the advanced counselor must master the diagnostic nuances separating characterological traits from substance-driven behaviors, understand the neurobiology and clinical dynamics of psychological trauma, differentiate primary psychotic illness from toxic delirium, and apply SAMHSA's Four Quadrants of Co-Occurring Severity model.

1. Cluster B Personality Disorders in Addiction Treatment

Cluster B personality disorders (characterized by dramatic, emotional, or erratic behaviors) exhibit exceptionally high comorbidity with substance use disorders. Two specific disorders—Borderline Personality Disorder (BPD) and Antisocial Personality Disorder (ASPD)—present distinct clinical challenges in addiction treatment.

Borderline Personality Disorder (BPD)

Clinical Profile: Characterized by a pervasive pattern of instability in interpersonal relationships, self-image, and affects, alongside marked impulsivity beginning by early adulthood. Diagnostic hallmarks include frantic efforts to avoid real or imagined abandonment, unstable and intense interpersonal relationships alternating between extremes of idealization and devaluation ( splitting ), identity disturbance, chronic feelings of emptiness, stress-induced transient paranoid ideation or severe dissociation, and intense episodic dysphoria, irritability, or anxiety.

Self-Harm vs. Suicidality: Clients with BPD exhibit recurrent suicidal behavior, gestures, or threats, alongside non-suicidal self-injury (NSSI) (e.g., superficial cutting, burning, scratching). In advanced clinical practice, NSSI is recognized as a maladaptive affect-regulation strategy to alleviate intolerable psychic pain or counter emotional numbness, rather than an intent to die. However, because NSSI co-occurs with high impulsivity and substance misuse, the lifetime completed suicide rate in BPD is approximately 8% to 10%—more than 50 times that of the general population.

Evidence-Based Integration: The gold-standard psychosocial intervention for co-occurring SUD and BPD is Dialectical Behavior Therapy (DBT) , developed by Marsha Linehan. DBT synthesizes behavioral change technologies with Zen mindfulness and radical acceptance across four core skill modules:

Core Mindfulness: Cultivating non-judgmental present-moment awareness to counteract dissociation and emotional reactivity.

Distress Tolerance: Surviving crises without making them worse (TIPP skills, self-soothing, radical acceptance) to replace substance use and NSSI during acute distress.

Emotion Regulation: Identifying and labeling emotions, increasing positive emotional events, and acting opposite to emotional urges.

Interpersonal Effectiveness: Asserting needs and setting boundaries while maintaining self-respect and relationship integrity (DEAR MAN, GIVE, FAST skills).

Managing Splitting: In treatment facilities, clients with BPD frequently engage in splitting by designating certain staff members as "all-good" saviors while demonizing others as "all-bad" persecutors. The clinical team must maintain unwavering, transparent communication, conduct regular multidisciplinary team consultation meetings, and enforce consistent, non-punitive clinical boundaries to prevent team fracturing.

Antisocial Personality Disorder (ASPD)

Clinical Profile: A pervasive pattern of disregard for and violation of the rights of others occurring since age 15, indicated by failure to conform to social norms and lawful behaviors, pervasive deceitfulness (repeated lying, use of aliases, or conning others for personal profit or pleasure), impulsivity, irritability and aggressiveness (repeated physical fights or assaults), reckless disregard for safety of self or others, consistent irresponsibility, and a lack of remorse (being indifferent to or rationalizing having hurt, mistreated, or stolen from another).

The Non-Negotiable Prerequisite: Under DSM-5-TR, ASPD cannot be diagnosed unless there is documented evidence that the individual met criteria for Conduct Disorder with onset before age 15 (manifested by aggression to people and animals, destruction of property, deceitfulness or theft, or serious violations of rules).

The Critical Differential: The counselor must differentiate genuine ASPD from substance-induced or drug-seeking antisocial behavior. An individual with an opioid or stimulant use disorder who engages in theft, forgery, or deceptive behavior solely to obtain funds to prevent withdrawal—but who demonstrates genuine remorse, empathy, prosocial values, and lawful functioning during periods of abstinence and before substance onset—does not have Antisocial Personality Disorder.

Clinical Management: Clients with ASPD respond poorly to unstructured, insight-oriented therapy. Effective management requires clear, firm behavioral contingency contracts, highly structured program rules, consistent enforcement of consequences, objective verification of self-reports (collateral contacts, toxicology), and focus on the practical, tangible self-interest of prosocial behavior.

2. Personality Disorder vs. Substance-Induced Behavioral Aberration

Clinical Domain Borderline Personality Disorder (BPD) Antisocial Personality Disorder (ASPD) Substance-Driven Behavioral Aberration

Developmental Onset Early adolescence; severe emotional lability, attachment trauma, identity crisis Onset of Conduct Disorder before age 15; chronic childhood aggression/rule-breaking Onset strictly corresponds with chemical dependence, dose escalation, or withdrawal

Interpersonal Stance Intense, frantic fear of abandonment; alternating idealization and devaluation Exploitative, callous, remorseless manipulation for personal gain or amusement Relational conflicts occur primarily around procurement, concealment, or financial distress

Affective Experience Extreme emotional dysregulation; chronic emptiness; intense shame and psychic pain Shallow affect; low anxiety; calloused indifference to distress of others Affective lability driven by intoxication crashes, withdrawal, or chemical cravings

Capacity for Remorse High; profound guilt and self-loathing following emotional or behavioral outbursts Absent; rationalization, minimization, or blaming victims for their exploitation Present; genuine remorse, guilt, and moral distress over harm inflicted while using

Response to Abstinence Relational instability and affective dysregulation persist; requires DBT Callous traits and rule violations persist; poor response to insight therapy Deceitful and illegal behaviors cease completely upon achieving stable sobriety

3. Trauma-Related Disorders: PTSD, Complex PTSD, and SUD

Post-Traumatic Stress Disorder (PTSD) and substance use disorders exhibit a deeply entrenched reciprocal relationship. Clinical studies indicate that up to 50% of individuals seeking addiction treatment meet diagnostic criteria for current PTSD.

The Four DSM-5-TR PTSD Symptom Clusters

Following exposure to actual or threatened death, serious injury, or sexual violence (Criterion A), PTSD manifests across four distinct symptom clusters persisting for > 1 >1 > 1 month:

Intrusion Symptoms (Criterion B): Recurrent, involuntary, and intrusive distressing memories; traumatic nightmares; dissociative flashbacks where the individual feels or acts as if the traumatic event were recurring; intense physiological reactivity to trauma cues.

Persistent Avoidance (Criterion C): Effortful avoidance of internal trauma-related distressing memories, thoughts, or feelings, and external reminders (people, places, conversations, activities, objects, situations) that arouse trauma memories.

Negative Alterations in Cognitions and Mood (Criterion D): Inability to remember key aspects of the trauma (dissociative amnesia); persistent exaggerated negative beliefs about oneself or the world ("I am bad," "No one can be trusted"); distorted cognitions leading to self-blame; persistent negative emotional state (fear, horror, anger, guilt); marked anhedonia; feelings of detachment from others.

Alterations in Arousal and Reactivity (Criterion E): Irritable behavior and angry outbursts; reckless or self-destructive behavior; hypervigilance; exaggerated startle response; concentration impairment; sleep disturbance.

Complex PTSD (C-PTSD)

Recognized in the ICD-11 and clinical traumatology, Complex PTSD arises from prolonged, repeated, or inescapable interpersonal trauma (e.g., severe childhood physical/sexual abuse, chronic domestic captivity, human trafficking). C-PTSD encompasses all core PTSD symptoms alongside profound disturbances in self-organization: severe emotional dysregulation, persistent beliefs about oneself as diminished, defeated, or worthless, and persistent difficulties in sustaining interpersonal relationships.

Self-Medication Hypothesis & The Mutual Maintenance Model

Khantzian's Self-Medication Hypothesis: Proposes that individuals do not abuse substances haphazardly; rather, specific classes of drugs are selected for their distinct psychopharmacological properties to self-regulate specific painful affective states. Trauma survivors often turn to central depressants (alcohol, benzodiazepines, opioids) to chemically dampen intrusive flashbacks, nightmare terror, and autonomic hyperarousal, or to psychostimulants to counter trauma-related emotional numbing, shame, and exhaustion.

Mutual Maintenance Model: Trauma and addiction feed into each other cyclically. Intrusive trauma symptoms trigger chemical cravings; acute intoxication impairs judgment and situational risk appraisal, leading to high-risk environments, physical assaults, and re-victimization; and neurobiological withdrawal severely exacerbates traumatic hypervigilance, creating an escalating spiral of mutual deterioration.

Clinical Best Practices: Advanced treatment requires integrated, trauma-informed addiction care such as Seeking Safety (developed by Lisa Najavits), an evidence-based cognitive-behavioral model addressing trauma and addiction simultaneously without requiring trauma narrative processing in early recovery, thereby preventing destabilization and relapse.

4. Severe Mental Illness (SMI): Primary Psychosis vs. Substance-Induced States

Differentiating primary psychotic disorders (Schizophrenia, Schizoaffective Disorder) from substance-induced psychotic disorders and toxic delirium is a critical life-safety responsibility.

Substance-Induced Psychotic Syndromes

Methamphetamine-Induced Psychosis: High doses of methamphetamine induce potent dopaminergic surge in the mesolimbic tract, causing intense persecutory delusions, extreme hypervigilance, and tactile hallucinations ( formication , often termed "meth bugs," prompting excoriation disorder/skin-picking). Symptoms generally resolve within days to weeks of cessation, though protracted or sensitized psychotic vulnerability may persist in chronic users.

Cannabis-Induced Psychotic Disorder: Ingestion of high-potency cannabis concentrates (dabs, wax, high-THC flower) or synthetic cannabinoids (e.g., K2, Spice, full cannabinoid receptor agonists) can precipitate acute persecutory paranoia, depersonalization, derealization, and agitation. Co-occurring Cannabis Hyperemesis Syndrome (CHS) —characterized by cyclical intractable nausea, abdominal pain, and compulsive hot bathing—is a pathognomonic physical marker of heavy cannabinoid toxicity.

Phencyclidine (PCP) / Ketamine Toxicity: Dissociative NMDA receptor antagonism produces profound toxic delirium, vertical or rotary nystagmus, physical anesthesia (leading to severe self-injury without perceived pain), extreme agitation, paranoia, and unpredictable violence.

Differentiating Toxic Delirium from Primary Schizophrenia

Diagnostic Feature Toxic Delirium / Substance Toxicity Primary Schizophrenia

Level of Consciousness Fluctuating, clouded sensorium; altered alertness; periods of lethargy alternating with agitation Alert and clear sensorium; consciousness is unimpaired

Cognitive Orientation Disoriented to time, place, or situation; severe working memory and attention deficits Typically oriented to person, place, and time; attention variable but sensorium intact

Hallucinatory Modality Predominantly visual, tactile (formication), or olfactory hallucinations Predominantly auditory hallucinations (voices conversing, commenting, or issuing commands)

Delusional Structure Fragmented, shifting, non-systematized persecutory delusions Complex, systematized, bizarre delusions (e.g., thought insertion, external control, passivity)

Negative Symptoms Absent; affect is volatile, terrified, or reactive to toxic delirium Prominent negative symptoms: avolition, alogia, flat affect, profound asociality

Onset & Trajectory Rapid, acute onset time-locked to substance intake; fluctuates; resolves with elimination Insidious prodromal deterioration over months/years in late adolescence/early adulthood; chronic

5. SAMHSA Four Quadrants of Co-Occurring Severity

The Substance Abuse and Mental Health Services Administration (SAMHSA) developed the Four Quadrants of Co-Occurring Severity model to guide system-level triage, resource allocation, and level-of-care matching based on the independent severity of psychiatric illness and substance use disorder. HIGH MENTAL HEALTH SEVERITY

  • │
  • Quadrant II │ Quadrant IV
  • (Specialty │ (Integrated
  • Mental Health │ Dual Disorder
  • Programs) │ Inpatient/ACT)
  • ─────────────────┼──────────────────
  • Quadrant I │ Quadrant III
  • (Primary Care │ (Specialty
  • / Outpatient │ Addiction
  • General) │ Treatment)
  • │
  • LOW MENTAL HEALTH SEVERITY
  • ───────────────┬───────────────────>
  • LOW SUD │ HIGH SUD
  • SEVERITY │ SEVERITY
  • The Four Quadrants Matrix

Quadrant Clinical Severity Profile Recommended Primary Locus of Care Clinical Staffing & Program Philosophy Primary Clinical Focus

Quadrant I Low Mental Illness; Low Substance Use Primary care clinics, student health centers, general outpatient medical practices General medical practitioners, outpatient counselors; consultation as needed Screening, brief interventions (SBIRT), health education, watchful waiting, lifestyle modification

Quadrant II High Mental Illness; Low Substance Use Specialty Community Mental Health Centers (CMHC), psychiatric outpatient clinics Psychiatrists, psychiatric nurse practitioners, licensed mental health clinicians, SUD cross-consultants Intensive psychiatric stabilization, case management, symptom monitoring, supportive addiction counseling

Quadrant III Low Mental Illness; High Substance Use Specialty addiction treatment facilities (IOP, residential addiction rehab) Licensed addiction counselors (AADC, LCADC), addiction medicine physicians, psychiatric consultants Medical detoxification, addiction rehabilitation, 12-step/peer recovery integration, supportive mental health monitoring

Quadrant IV High Mental Illness; High Substance Use Integrated Dual Disorder Treatment (IDDT) programs, psychiatric inpatient hospitals, ACT teams Multidisciplinary teams dually credentialed in psychiatry and addiction; 24-hour intensive medical/crisis staffing Comprehensive, concurrent integrated treatment; assertive community outreach; crisis containment; intensive case management

  • 6. Comprehensive Clinical Vignette & Multi-Diagnostic Formulation
  • Clinical Case Presentation

A 31-year-old female presents for admission to an intensive outpatient co-occurring treatment facility. Her history reveals daily intravenous fentanyl use (10 bags daily) and heavy episodic alcohol binging. She reports a history of severe physical and sexual trauma during childhood and domestic violence in adult relationships.

Mental status examination reveals intense emotional lability, tearful demands for reassurance, and hypervigilant scanning of the clinic room. She reports recurrent nightmares of her assaults, terrifying waking flashbacks, and avoidance of all male authority figures. She also displays numerous superficial cutting scars on both forearms, explaining: "When the emotional terror and emptiness become suffocating, cutting is the only thing that brings me back to reality and stops the panic." During intake, she alternates between praising the intake clinician as "my guardian angel who is finally going to save my life" and expressing intense hostility toward the clinical director who informed her of the program's contraband policy. Collateral records confirm that she has experienced two non-fatal opioid overdoses in the past four months, both occurring immediately following intense interpersonal breakups.

Master's-Level Diagnostic Formulation

Axis I / Clinical Psychiatric Formulation:

Severe Opioid Use Disorder, active, on agonist therapy evaluation.

Severe Alcohol Use Disorder, episodic.

Post-Traumatic Stress Disorder (PTSD): Meets full diagnostic criteria across all four clusters (Criterion B intrusion: nightmares, flashbacks; Criterion C avoidance: avoiding trauma triggers; Criterion D negative cognitions/mood: persistent terror, emotional numbness; Criterion E hyperarousal: hypervigilance, insomnia).

Axis II / Personality Functioning Formulation:

Borderline Personality Features (BPD): Demonstrates prominent affective instability, intense fear of abandonment, splitting defense mechanisms, and recurrent non-suicidal self-injury (NSSI) utilized for affect regulation. A formal diagnosis of BPD should remain provisional until sustained sobriety is achieved, though clinical management must immediately incorporate BPD-specific protocols.

SAMHSA Quadrant Placement:

Quadrant IV (High Mental Health Severity, High Substance Use Severity): Demands an integrated, multidisciplinary dual-disorder treatment approach.

Integrated Treatment Plan Sequencing:

Phase 1 (Immediate Safety & Medical Stabilization): Initiate Medication for Opioid Use Disorder (MOUD, e.g., buprenorphine/naloxone) to extinguish opioid withdrawal and eliminate overdose lethality; distribute naloxone kits; execute a collaborative crisis and safety plan addressing NSSI and overdose risk.

Phase 2 (Trauma-Informed Skills Training): Enroll client in Dialectical Behavior Therapy (DBT) skills training (distress tolerance, emotion regulation) combined with Seeking Safety modules. Explicitly avoid trauma narrative exposure therapies (e.g., prolonged exposure) during early stabilization to prevent decompensation.

Phase 3 (Relapse Prevention & Systemic Support): Maintain weekly multidisciplinary team consultation to manage splitting; establish firm, consistent boundaries; cultivate prosocial dual-recovery community capital.